{
  "ticker": "MGTX",
  "company_name": "MeiraGTx Holdings plc",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03758404",
      "title": "Gene Therapy for Achromatopsia (CNGA3)",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Achromatopsia",
      "start_date": "2019-08-12",
      "completion_date": "2021-06-10",
      "enrollment": 0,
      "sponsor": "MeiraGTx UK II Ltd"
    },
    {
      "nct_id": "NCT02781480",
      "title": "Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA)",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Leber Congenital Amaurosis",
      "start_date": "2016-04",
      "completion_date": "2018-12",
      "enrollment": 0,
      "sponsor": "MeiraGTx UK II Ltd"
    },
    {
      "nct_id": "NCT03278873",
      "title": "Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3",
      "status": "TERMINATED",
      "phase": "",
      "condition": "Achromatopsia",
      "start_date": "2017-06-29",
      "completion_date": "2024-04-04",
      "enrollment": 0,
      "sponsor": "MeiraGTx UK II Ltd"
    },
    {
      "nct_id": "NCT05060341",
      "title": "Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "",
      "condition": "Radiation-induced Xerostomia",
      "start_date": "2020-11-12",
      "completion_date": "2027-03",
      "enrollment": 0,
      "sponsor": "MeiraGTx, LLC"
    },
    {
      "nct_id": "NCT06544798",
      "title": "Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia",
      "status": "ENROLLING_BY_INVITATION",
      "phase": "PHASE2",
      "condition": "Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands",
      "start_date": "2024-08-02",
      "completion_date": "2032-02",
      "enrollment": 0,
      "sponsor": "MeiraGTx, LLC"
    },
    {
      "nct_id": "NCT02946879",
      "title": "Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Leber Congenital Amaurosis (LCA), Eye Diseases, Eye Diseases, Hereditary, Retinal Diseases",
      "start_date": "2016-11",
      "completion_date": "2023-07",
      "enrollment": 0,
      "sponsor": "MeiraGTx UK II Ltd"
    },
    {
      "nct_id": "NCT03349242",
      "title": "Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Retinitis Pigmentosa",
      "start_date": "2017-12-19",
      "completion_date": "2024-04-19",
      "enrollment": 0,
      "sponsor": "MeiraGTx UK II Ltd"
    },
    {
      "nct_id": "NCT03001310",
      "title": "Gene Therapy for Achromatopsia (CNGB3)",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Achromatopsia",
      "start_date": "2017-01-16",
      "completion_date": "2019-10-25",
      "enrollment": 0,
      "sponsor": "MeiraGTx UK II Ltd"
    },
    {
      "nct_id": "NCT04043104",
      "title": "A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Radiation-Induced Parotid Gland Hypofunction, Xerostomia Due to Radiotherapy, Head and Neck Cancer",
      "start_date": "2019-06-30",
      "completion_date": "2023-03-28",
      "enrollment": 0,
      "sponsor": "MeiraGTx UK II Ltd"
    },
    {
      "nct_id": "NCT05926765",
      "title": "A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands",
      "start_date": "2023-06-13",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "MeiraGTx, LLC"
    }
  ],
  "summary": {
    "total_trials": 16,
    "by_phase": {
      "PHASE1, PHASE2": 6,
      "": 6,
      "PHASE2": 2,
      "PHASE1": 2
    },
    "by_status": {
      "COMPLETED": 10,
      "TERMINATED": 1,
      "ACTIVE_NOT_RECRUITING": 3,
      "ENROLLING_BY_INVITATION": 1,
      "RECRUITING": 1
    },
    "active_trials": 5,
    "completed_trials": 10,
    "conditions": [
      "Achromatopsia",
      "Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands",
      "Leber Congenital Amaurosis",
      "Leber Congenital Amaurosis (LCA), Eye Diseases, Eye Diseases, Hereditary, Retinal Diseases",
      "Parkinson's Disease",
      "Radiation-Induced Parotid Gland Hypofunction, Xerostomia Due to Radiotherapy, Head and Neck Cancer",
      "Radiation-induced Xerostomia",
      "Retinitis Pigmentosa",
      "Squamous Cell Head and Neck Cancer, Radiation Induced Xerostomia, Salivary Hypofunction",
      "X-Linked Retinitis Pigmentosa"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:58.916753",
    "search_query": "MeiraGTx Holdings plc",
    "url": "https://clinicaltrials.gov/search?term=MeiraGTx+Holdings+plc"
  }
}